March 16, 2016 – Rockhold, a leading biostatistician and proven leader in research and development, brings more than 30 years of diverse experience to the DCRI.
The DCRI today announced that Frank Rockhold, PhD, has been appointed professor of biostatistics and bioinformatics. A leading biostatistician in the pharmaceutical industry, Rockhold has more than 30 years of diverse experience in clinical trial design, data monitoring, decision sciences, statistical research, and epidemiology. He has a consistent record of leadership in improving the quality and safety of clinical trial protocols and increasing trial efficacy through innovative design, data mining, and extended use of epidemiology.
“Throughout his impressive career, Dr. Rockhold has championed the importance of open access to patient-level clinical data,” said DCRI Executive Director Eric Peterson, MD, MPH. “With his expertise in biostatistics research and clinical trial design and data monitoring, Dr. Rockhold is an invaluable addition to our team of some of the world’s foremost authorities on clinical research.”
“As the world’s largest academic research organization, the Duke Clinical Research Institute is well known for the vital research it conducts, as well as its efforts to make data accessible for the benefit of patients everywhere,” said Rockhold. “I am excited to join the DCRI and support its mission to improve patient care and the practice of medicine around the world.”
Rockhold was most recently senior vice president of Global Clinical Safety and Pharmacovigilance at GlaxoSmithKline, and prior to that ran Cardiovascular and Metabolic Development and the Biostatistics, Epidemiology and Healthcare Informatics departments. Earlier in his career, he held positions with Merck Research Laboratories and Lilly Research Laboratories. Rockhold is a well-respected researcher with more than 175 publications and presentations in major scientific journals across a wide variety of topics. He holds adjunct professor appointments at two leading Pennsylvania universities.
He served on the board of directors of the Clinical Data Interchange Standards Consortium, most recently as Chairman, is past president of the Society for Clinical Trials, is a fellow of both the American Statistical Association and the Society for Clinical Trials, and is an accredited professional statistician. Rockhold received his PhD in biostatistics from the Medical College of Virginia, his ScM in biostatistics from The Johns Hopkins University, and his BA in statistics from the University of Connecticut.